DABCYL acid
Order now: dominika@ksiazkiwnauce.pl
5'-DABCYL C6 phosphoramidite |
|||
| 6009 | AAT Bioquest | 1 g | 1051.2 EUR |
Fmoc-Lys(Dabcyl)-OH |
|||
| 5-06693 | CHI Scientific | 250mg | Ask for price |
Fmoc-Lys(Dabcyl)-OH |
|||
| 5-06694 | CHI Scientific | 1g | Ask for price |
DABCYL succinimidyl ester [4-((4-(Dimethylamino)phenyl)azo)benzoic acid, succinimidyl ester] *CAS 146998-31-4* |
|||
| 2004 | AAT Bioquest | 1 g | 420 EUR |
DABCYL succinimidyl ester [4-((4-(Dimethylamino)phenyl)azo)benzoic acid, succinimidyl ester] *CAS 146998-31-4* |
|||
| 2005 | AAT Bioquest | 5 g | 1573.2 EUR |
FMOC-Lys(DABCYL)-OH *CAS 146998-27-8* |
|||
| 5040 | AAT Bioquest | 100 mg | 158.4 EUR |
FMOC-Lys(DABCYL)-OH *CAS 146998-27-8* |
|||
| 5041 | AAT Bioquest | 1 g | 471.6 EUR |
DABCYL-TNF-a-EDANS (-4 to +6) (human) |
|||
| M-2155.0001 | Bachem | 1.0mg | 471.6 EUR |
|
Description: Sum Formula: C70H104N22O18S; CAS# [396716-14-6] net |
|||
DABCYL-TNF-a-EDANS (-4 to +6) (human) |
|||
| M-2155.0005 | Bachem | 5.0mg | 1778.4 EUR |
|
Description: Sum Formula: C70H104N22O18S; CAS# [396716-14-6] net |
|||
DABCYL-Arg-Gly-Val-Val-Asn-Ala-OH |
|||
| H-2442.0001 | Bachem | 1.0mg | 618 EUR |
|
Description: Sum Formula: C40H59N13O9; CAS# [289898-42-6] |
|||
DABCYL-Arg-Gly-Val-Val-Asn-Ala-OH |
|||
| H-2442.0005 | Bachem | 5.0mg | 2358 EUR |
|
Description: Sum Formula: C40H59N13O9; CAS# [289898-42-6] |
|||
DABCYL-ERNleFLSFP-EDANS, Malaria Aspartyl Proteinase FRET Substrate I |
|||
| MAPF15-P-5 | Alpha Diagnostics | 5 mg | 1512 EUR |
DABCYL-Tyr-Val-Ala-Asp-Ala-Pro-Val-EDANS |
|||
| M-1940.0001 | Bachem | 1.0mg | 642 EUR |
|
Description: Sum Formula: C61H76N12O14S; CAS# [161877-70-9] net |
|||
DABCYL-Tyr-Val-Ala-Asp-Ala-Pro-Val-EDANS |
|||
| M-1940.0005 | Bachem | 5.0mg | 2431.2 EUR |
|
Description: Sum Formula: C61H76N12O14S; CAS# [161877-70-9] net |
|||
DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS |
|||
| M-2120.0001 | Bachem | 1.0mg | 471.6 EUR |
|
Description: Sum Formula: C76H98N16O15S; CAS# [263718-22-5] net |
|||
DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS |
|||
| M-2120.0005 | Bachem | 5.0mg | 1778.4 EUR |
|
Description: Sum Formula: C76H98N16O15S; CAS# [263718-22-5] net |
|||
DABCYL-GABA-ERMFLSFP-EDANS, Hemoglobin, 3037a, Malaria FRET Substrate II |
|||
| HBG25-P | Alpha Diagnostics | 1 mg | 489.6 EUR |
DABCYL-GABA-ALERMFLSFP-EDANS, Hemoglobin, 2837a, Malaria FRET Substrate III |
|||
| HBG31-P | Alpha Diagnostics | 1 mg | 489.6 EUR |
DABCYL-(Asn670,Leu671)-Amyloid b/A4 Protein Precursor770 (667-675)-EDANS |
|||
| M-2435.0001 | Bachem | 1.0mg | 417.6 EUR |
|
Description: Sum Formula: C71H91N15O21S; CAS# [1802078-36-9] net |
|||
DABCYL-(Asn670,Leu671)-Amyloid b/A4 Protein Precursor770 (667-675)-EDANS |
|||
| M-2435.0005 | Bachem | 5.0mg | 1446 EUR |
|
Description: Sum Formula: C71H91N15O21S; CAS# [1802078-36-9] net |
|||
DABCYL-Lys-HCoV-SARS Replicase Polyprotein 1ab (3235-3246)-Glu-EDANS |
|||
| M-2575.0001 | Bachem | 1.0mg | 691.2 EUR |
|
Description: Sum Formula: C95H141N25O24S2; CAS# [730985-86-1] net |
|||
DABCYL-Lys-HCoV-SARS Replicase Polyprotein 1ab (3235-3246)-Glu-EDANS |
|||
| M-2575.0005 | Bachem | 5.0mg | 2648.4 EUR |
|
Description: Sum Formula: C95H141N25O24S2; CAS# [730985-86-1] net |
|||
DABCYL-g-Abu-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS |
|||
| M-1865.0001 | Bachem | 1.0mg | 471.6 EUR |
|
Description: Sum Formula: C73H97N17O18S; CAS# [127134-13-8] net |
|||
DABCYL-g-Abu-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS |
|||
| M-1865.0005 | Bachem | 5.0mg | 1778.4 EUR |
|
Description: Sum Formula: C73H97N17O18S; CAS# [127134-13-8] net |
|||
DABCYL-g-Abu-Pro-Gln-Gly-Leu-Glu(EDANS)-Ala-Lys-NH2 |
|||
| M-2495.0001 | Bachem | 1.0mg | 1009.2 EUR |
|
Description: Sum Formula: C63H88N16O14S; CAS# [193475-71-7] |
|||
DABCYL-g-Abu-Pro-Gln-Gly-Leu-Glu(EDANS)-Ala-Lys-NH2 |
|||
| M-2495.0005 | Bachem | 5.0mg | 3924 EUR |
|
Description: Sum Formula: C63H88N16O14S; CAS# [193475-71-7] |
|||
H-Glu(EDANS)-Pro-Leu-Phe-Ala-Glu-Arg-Lys(DABCYL)-OH |
|||
| M-2655.0001 | Bachem | 1.0mg | 400.8 EUR |
|
Description: Sum Formula: C72H97N17O16S; CAS# [1914987-47-5] |
|||
H-Glu(EDANS)-Pro-Leu-Phe-Ala-Glu-Arg-Lys(DABCYL)-OH |
|||
| M-2655.0005 | Bachem | 5.0mg | 1488 EUR |
|
Description: Sum Formula: C72H97N17O16S; CAS# [1914987-47-5] |
|||
DABCYL-ERNleFLSFP-EDANS, Malaria Aspartyl Proteinase FRET (Fluorescence Resonance Energy Transfer) Substrate I |
|||
| MAPF15-P | Alpha Diagnostics | 1 mg | 416.4 EUR |
Okadaic acid, free acid |
|||
| OL1198 | Bio Basic | 50ug | 231.22 EUR |
Octanoic acid (Caorylic acid) |
|||
| O5678 | Bio Basic | 250ml | 80.88 EUR |
Fumalic acid(Ferulic acid) |
|||
| E1KS2300 | EnoGene | 50mg | 390 EUR |
DABCYL-g-Abu-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Thr-EDANS |
|||
| M-2050.0001 | Bachem | 1.0mg | 792 EUR |
|
Description: Sum Formula: C90H120N22O16S; CAS# [142988-22-5] net |
|||
DABCYL-g-Abu-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Thr-EDANS |
|||
| M-2050.0005 | Bachem | 5.0mg | 3054 EUR |
|
Description: Sum Formula: C90H120N22O16S; CAS# [142988-22-5] net |
|||
Ac-Asp-Glu-Asp(EDANS)-Glu-Glu-Abu-L-lactoyl-Ser-Lys(DABCYL)-NH2 |
|||
| M-2235.0500 | Bachem | 0.5mg | 486 EUR |
|
Description: Sum Formula: C68H89N15O25S; CAS# [188530-20-3] net |
|||
Ac-Asp-Glu-Asp(EDANS)-Glu-Glu-Abu-L-lactoyl-Ser-Lys(DABCYL)-NH2 |
|||
| M-2235.1000 | Bachem | 1.0mg | 835.2 EUR |
|
Description: Sum Formula: C68H89N15O25S; CAS# [188530-20-3] net |
|||
H-Glu(EDANS)-Lys-Pro-Ala-Lys-Phe-Phe-Arg-Leu-Lys(DABCYL)-NH2 |
|||
| M-2535.0001 | Bachem | 1.0mg | 588 EUR |
|
Description: Sum Formula: C88H124N22O15S; CAS# [1926163-42-9] net |
|||
H-Glu(EDANS)-Lys-Pro-Ala-Lys-Phe-Phe-Arg-Leu-Lys(DABCYL)-NH2 |
|||
| M-2535.0005 | Bachem | 5.0mg | 2242.8 EUR |
|
Description: Sum Formula: C88H124N22O15S; CAS# [1926163-42-9] net |
|||
DL-Maleic acid (Toxilic acid) |
|||
| MA0333 | Bio Basic | 250g | 77.4 EUR |
D-Glucuronic acid, free acid |
|||
| GB0482 | Bio Basic | 5g | 186.19 EUR |
MUCOBROMIC ACID (2,3‐ DIBROMOMALEALDEHYDIC ACID) |
|||
| 613004 | Survival Technologies | each | Ask for price |
Arg-Glu(EDANS)-(Asn670,Leu671)-Amyloid b/A4 Protein Precursor770 (668-675)-Lys(DABCYL)-Arg |
|||
| M-2470.0001 | Bachem | 1.0mg | 618 EUR |
|
Description: Sum Formula: C91H129N25O25S; CAS# [310427-94-2] net |
|||
Arg-Glu(EDANS)-(Asn670,Leu671)-Amyloid b/A4 Protein Precursor770 (668-675)-Lys(DABCYL)-Arg |
|||
| M-2470.0005 | Bachem | 5.0mg | 2358 EUR |
|
Description: Sum Formula: C91H129N25O25S; CAS# [310427-94-2] net |
|||
Asterric Acid |
|||
| A132-1MG | TOKU-E | 1 mg | 313.2 EUR |
Asterric Acid |
|||
| A132-5MG | TOKU-E | 5 mg | 1006.8 EUR |
Zoledronic Acid |
|||
| A1352-100 | ApexBio | 100 mg | 268.8 EUR |
|
Description: Zoledronic acid, one of the most potent nitrogen-containing bisphosphonates, induces anti-proliferative and apoptotic effects on multiple myeloma cell lines in vitro by activating protein kinase C. Zoledronic acid also inhibits proliferation of human foet |
|||
Zoledronic Acid |
|||
| A1352-25 | ApexBio | 25 mg | 129.6 EUR |
|
Description: Zoledronic acid, one of the most potent nitrogen-containing bisphosphonates, induces anti-proliferative and apoptotic effects on multiple myeloma cell lines in vitro by activating protein kinase C. Zoledronic acid also inhibits proliferation of human foet |
|||
Zoledronic Acid |
|||
| A1352-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Zoledronic acid, one of the most potent nitrogen-containing bisphosphonates, induces anti-proliferative and apoptotic effects on multiple myeloma cell lines in vitro by activating protein kinase C. Zoledronic acid also inhibits proliferation of human foet |
|||